Venus Medtech (Hangzhou) Inc

02500

Company Profile

  • Business description

    Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, namely VenusA-Valve, and VenusA-Plus. VenusA-Valve is its first-generation TAVR device, which is used to treat severe Aortic Stenosis (AS) using a transcatheter approach. VenusA-Plus is an upgraded product of VenusA-Valve. Geographically majority of the revenue is derived from Mainland China.

  • Contact

    No. 88, Jiangling Road
    Room 311, 3rd Floor, Block 2
    Binjiang District
    Hangzhou310051
    CHN

    T: +86 57187772180

    https://www.venusmedtech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    691

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,789.4045.800.52%
CAC 407,691.55134.241.78%
DAX 4024,033.22383.921.62%
Dow JONES (US)43,819.27432.431.00%
FTSE 1008,798.9163.310.72%
HKSE24,182.95101.20-0.42%
NASDAQ20,273.46105.550.52%
Nikkei 22540,624.59473.801.18%
NZX 50 Index12,565.1218.47-0.15%
S&P 5006,173.0732.050.52%
S&P/ASX 2008,561.4047.200.55%
SSE Composite Index3,431.186.950.20%

Market Movers